Phio Pharmaceuticals Corp. (PHIO) Operating income 2016–2025
Phio Pharmaceuticals Corp. (PHIO) annual operating income history from SEC filings — each fiscal year as reported.
-$9.2MFY2025 · since FY2016: -$9.0M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -24.8% |
| FY2024 | -$7.4M | +31.8% |
| FY2023 | -$10.8M | +5.6% |
| FY2022 | -$11.5M | +15.2% |
| FY2021 | -$13.5M | -53.7% |
| FY2020 | -$8.8M | +2.2% |
| FY2019 | -$9.0M | -22.0% |
| FY2018 | -$7.4M | +47.6% |
| FY2017 | -$14.1M | -56.0% |
| FY2016 | -$9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHIO financial trends
PHIO RevenuePHIO Net incomePHIO Net marginPHIO Gross profitPHIO Gross marginPHIO Operating marginPHIO Operating cash flowPHIO Free cash flowPHIO Capital expendituresPHIO Return on equityPHIO Stock buybacksPHIO Dividends paidPHIO Total assetsPHIO Total liabilitiesPHIO Shareholders’ equityPHIO overview →